ALX Oncology Holdings Inc balance sheet

At the end of fiscal 2022, ALX Oncology Holdings Inc had total assets of $306m, total liabilities of $43.0m and shareholders' equity of $263m. It held $48.8m in cash against $10.6m of debt: net cash of $38.2m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

ALX Oncology Holdings Inc: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022
Cash and equivalents	8	9	434	364	49
Total current assets	—	10	436	367	271
Total assets	—	11	436	380	306
Accounts payable	—	4	0	4	8
Total current liabilities	—	5	6	15	28
Short-term debt	—	—	—	—	0
Long-term debt	—	5	—	—	9
Total debt	0	5	—	0	11
Total liabilities	—	11	6	17	43
Shareholders' equity	−52	−71	430	363	263
Non-controlling interests and other (assets − liabilities − equity)	—	70	—	—	—
Net debt (negative = net cash)	−8	−4	−434	−364	−38
Shares outstanding	—	3m	—	41m	41m

US$ millions unless shown otherwise. Fiscal quarters.

ALX Oncology Holdings Inc: balance sheet, quarterly
Quarter	2019 Q2Jun 2019	2019 Q3Sept 2019	2019 Q4Dec 2019	2020 Q1Mar 2020	2020 Q2Jun 2020	2020 Q3Sept 2020	2020 Q4Dec 2020
Total current assets	—	—	10	—	101	262	436
Total assets	—	—	11	—	103	262	436
Accounts payable	—	—	4	—	2	1	0
Total current liabilities	—	—	5	—	8	7	6
Short-term debt	—	—	—	—	2	3	—
Long-term debt	—	—	5	—	4	3	—
Total debt	—	—	5	—	6	6	—
Total liabilities	—	—	11	—	12	10	6
Shareholders' equity	−60	−63	−71	−76	−84	252	430
Non-controlling interests and other (assets − liabilities − equity)	—	—	70	—	175	—	—
Shares outstanding	—	—	3m	—	3m	37m	40m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from ALX Oncology Holdings Inc's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to ALX Oncology Holdings Inc.